UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023390
Receipt number R000026941
Scientific Title Double-blind randomized parallel intergroup trial about the efficacy of the immobilized antibacterial ingredient Etak processing shirt for atopic dermatitis
Date of disclosure of the study information 2016/07/29
Last modified on 2022/02/01 13:29:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Double-blind randomized parallel intergroup trial about the efficacy of the immobilized antibacterial ingredient Etak processing shirt for atopic dermatitis

Acronym

Double-blind randomized parallel intergroup trial about the efficacy of the immobilized antibacterial ingredient Etak processing shirt for atopic dermatitis

Scientific Title

Double-blind randomized parallel intergroup trial about the efficacy of the immobilized antibacterial ingredient Etak processing shirt for atopic dermatitis

Scientific Title:Acronym

Double-blind randomized parallel intergroup trial about the efficacy of the immobilized antibacterial ingredient Etak processing shirt for atopic dermatitis

Region

Japan


Condition

Condition

atopic dermatitis

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

There is that we test the advantage of the improvement effect on placebo shirt of the Etak processing shirt (change> of score <physique part [shirt wearing site] objective SCORAD by the diagnosis of the atopic symptom by the physician) of atopic dermatitis by the multicenter randomized parallel intergroup trial for the patients 70 years or younger 16 years old that a symptom of atopic dermatitis is stable in its or older for the purpose of this study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

SCORAD

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

the immobilized antibacterial ingredient Etak processing shirt

Interventions/Control_2

Shirt roughness

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Age at agreement acquisition is the patient 70 years or younger 16 years old or older

The patients with atopic dermatitis (the patients that a rank of the steroid medicine for external application prescribed for one month does not have a change) who are stable in their symptom for one month

The patients that there is not serious underlying disease such as the serious heart disorder, and the overall status is stable

The patients that an agreement is obtained in a document from the person about participation of this study

Key exclusion criteria

The patients who receive steroid internal use therapy, cyclosporine internal use therapy

The patients in the physique part without a symptom of atopic dermatitis

The patients whom the shirt is not their size

The patients who admitted that it was inadequate so that a study person in charge or a study partaker underwent this study

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Shunsuke
Middle name
Last name Takahagi

Organization

Hiroshima University, Hiroshima, Japan

Division name

Department of Dermatology,

Zip code

734-8551

Address

1-2-3 Kasumi, minamiku ,Hiroshima ,Hiroshima University, Hiroshima, Japan

TEL

082-257-5238

Email

shunstk@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Tomofumi
Middle name
Last name Numata

Organization

Hiroshima University, Hiroshima, Japan

Division name

Department of Dermatology,

Zip code

734-8551

Address

1-2-3 Kasumi, minamiku ,Hiroshima ,Hiroshima University, Hiroshima, Japan

TEL

082-257-5238

Homepage URL


Email

t_numa_925@yahoo.co.jp


Sponsor or person

Institute

Department of Dermatology,Hiroshima University, Hiroshima, Japan

Institute

Department

Personal name



Funding Source

Organization

Department of Oral Biology & Engineering
Integrated Health Sciences
Institute of Biomedical and Health Sciences
Hiroshima University

Department of Dermatology,Hiroshima University, Hiroshima, Japan

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

1-2-3 Kasumi, minamiku ,Hiroshima ,Hiroshima University, Hiroshima, Japan

Tel

082-257-1551

Email

iryo-seisaku@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 29 Day

Date of IRB

2016 Year 07 Month 21 Day

Anticipated trial start date

2016 Year 07 Month 29 Day

Last follow-up date

2021 Year 10 Month 31 Day

Date of closure to data entry

2021 Year 10 Month 31 Day

Date trial data considered complete

2021 Year 10 Month 31 Day

Date analysis concluded

2021 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 07 Month 29 Day

Last modified on

2022 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026941


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name